Kochhar D M, Penner J D, McDay J A
Teratology. 1978 Aug;18(1):71-92. doi: 10.1002/tera.1420180111.
Various morphological and biochemical parameters were used to study the mode of interference by cytosine arabinoside (Ara-C) in critical phases of embryonic limb development. Inhibition of embryonic DNA synthesis occurred immediately after injection of Ara-C into the mother. The inhibition was dose-dependent and was substantial even after the nonteratogenic dose (2 mg/kg) of Arc-C. The pattern of limb bone deficiencies in Ara-C treated fetuses was specific for each developmental stage at which the treatment was given; the site of affect moved distalwards along the limb as the development advanced. The teratogenic dose was cytotoxic to mesenchymal cells with a high proliferation rate but did not affect others such as the future cartilage cells in which the rate of proliferation was lower. The existence of this differential susceptibility at each stage of development, together with information about the pattern of bone defects at the same stage, permitted us not only to define with some precision the cellular basis of origin of limb defects but also to infer the relative level of cell differentiation pertaining to each successive stage. Deoxycytidine, if injected simultaneously with and at doses eight times larger than Ara-C, afforded virtually complete protection against teratogenic effects. Deoxycytidine also prevented cell death in the limbs of Ara-C treated embryos. However, a dramatic increase in the frequency of polydactyly was found in the protected fetuses. The fact that the frequency of ectrodactyly in the protected fetuses decreased in inverse proportion to the frequency of polydactyly strengthened the notion that there may be a common cellular basis underlying these two types of digital defects. Striking changes were found in the structure of AER at 24 hours after Ara-C treatment; it was abnormally thickened into a gland-like structure and its inner edge facing the mesenchyme thickened into a gland-like structure and its inner edge facing the mesenchyme was thrown into several folds. This may constitute a response to impairment in the underlying mesenchyme with which AFR has long been considered to have an interdependent relationship.
运用多种形态学和生物化学参数研究了阿糖胞苷(Ara-C)在胚胎肢体发育关键阶段的干扰模式。向母体注射Ara-C后,胚胎DNA合成立即受到抑制。这种抑制呈剂量依赖性,即使在非致畸剂量(2mg/kg)的Ara-C作用后也很显著。Ara-C处理的胎儿肢体骨缺陷模式在给予处理的每个发育阶段都是特定的;随着发育推进,受影响部位沿肢体向远端移动。致畸剂量对增殖率高的间充质细胞具有细胞毒性,但不影响其他细胞,如增殖率较低的未来软骨细胞。发育各阶段这种差异敏感性的存在,连同同一阶段骨缺陷模式的信息,不仅使我们能够较为精确地确定肢体缺陷的细胞起源基础,还能推断与每个连续阶段相关的细胞分化相对水平。如果与Ara-C同时注射且剂量为其八倍,脱氧胞苷几乎能完全保护胚胎免受致畸影响。脱氧胞苷还能防止Ara-C处理的胚胎肢体中的细胞死亡。然而,在受保护的胎儿中发现多指畸形的频率显著增加。受保护胎儿中缺指畸形频率与多指畸形频率成反比下降,这一事实强化了这两种类型指缺陷可能存在共同细胞基础的观点。Ara-C处理24小时后,发现顶外胚层嵴(AER)结构发生显著变化;它异常增厚形成腺样结构,其面向间充质的内缘增厚并形成腺样结构,且内缘向间充质折叠形成数处褶皱。这可能是对其长期以来被认为与之相互依存的下层间充质损伤的一种反应。